Business Wire Feed
Luskin Orthopaedic Institute for Children Brings Holiday Cheer to 1,000 Children at 36th Annual Toys & Joy Celebration
Santa Arrives via Helicopter to Deliver Gifts LOS ANGELES--(BUSINESS WIRE)--#HolidayGiving--Luskin Orthopaedic Institute for Children (LuskinOIC) welcomed more than 1,000 pediatric patients and families to its Downtown Los Angeles campus for the nonprofit’s 36th Annual Toys more...
VASA Fitness Expands in Colorado With New Clubs in Longmont and Lafayette
High-Value, Full-Amenity Fitness Operator Brings Premium, Inclusive Fitness to Boulder County DENVER--(BUSINESS WIRE)--VASA Fitness, one of the nation’s largest high-value, low-price fitness operators, is opening two new locations in Boulder County, CO: Longmont and Lafayette, more...
VASA Fitness to Open 68th Club Nationwide in Rockford, IL
New Location in Northern Illinois Delivers VASA’s Signature Blend of Strength, Cardio, Boutique Classes, and Recovery Amenities ROCKFORD, Ill.--(BUSINESS WIRE)--VASA Fitness, one of the nation’s largest high-value, low-price fitness operators, is opening a new location more...
HBox Receives Strategic Growth Investment from Charlesbank Technology Opportunities Fund
BOSTON--(BUSINESS WIRE)--HBox (“HBox” or the “Company”), a leading virtual care platform for specialty practices, announced that it has received a growth investment from Charlesbank’s Technology Opportunities Fund (“TOF”) II. Amid rising chronic disease prevalence, expanding more...
ZOLL Launches Fifth-Generation LifeVest® WCD
CHELMSFORD, Mass.--(BUSINESS WIRE)--ZOLL®, an Asahi Kasei company that manufactures medical devices and related software solutions, announced the U.S. launch of the next generation LifeVest® wearable cardioverter defibrillator (WCD). This marks the fifth FDA-approved LifeVest WCD, more...
Sensorion to Present at the 44th Annual J.P. Morgan Healthcare Conference
MONTPELLIER, France--(BUSINESS WIRE)--Regulatory News: Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, announced today more...
Meiji Seika Pharma Partners With MBC BioLabs to Strengthen Global Innovation in Drug Discovery
TOKYO--(BUSINESS WIRE)--Meiji Seika Pharma Co., Ltd. (Headquarters: Chuo-ku, Tokyo; President & CEO: Toshiaki Nagasato) today announced that it has entered into a partnership agreement with MBC BioLabs which is a private organization supporting the development more...
CareDx Provides Notice of Proposed Derivative Settlement
BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) today provided notice of proposed settlement of derivative actions and settlement hearing. UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF CALIFORNIA JEFFREY EDELMAN, JAYSEN Case No. 3:25-cv-02036-TLT STEVENSON, and CHRISTIAN more...
MediTrans Appoints Derek Hoy as CEO, Strengthening Executive Leadership at a Pivotal Time in Louisiana
LAFAYETTE, La.--(BUSINESS WIRE)--#CEOAppointment--MediTrans, the largest Louisiana based non-emergency medical transportation (NEMT) brokerage, today announced the appointment of Derek Hoy as Chief Executive Officer, marking an important step in the company’s continued growth, operational investment, and more...
Arcus Biosciences to Participate in the 44th Annual J.P. Morgan Healthcare Conference
HAYWARD, Calif.--(BUSINESS WIRE)--Arcus Biosciences (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for patients with cancer, inflammatory and autoimmune diseases, announced that Terry Rosen, Ph.D., chief executive officer, will more...
Acadia Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 13, 2026
SAN DIEGO--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco, CA. Catherine Owen Adams, Chief Executive Officer will represent the company more...
Phreesia Named to The Software Report’s “Top 50 Software Companies” for the Fourth Consecutive Year
ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia, a leader in patient intake, outreach and activation, has been named one of The Software Report’s “Top 50 Software Companies of 2025.” The annual awards program recognizes outstanding companies based on more...
EBR Systems to Present at the J.P. Morgan 2026 Healthcare Conference
SUNNYVALE, Calif.--(BUSINESS WIRE)--EBR Systems, Inc., developer of the world’s only left ventricular wireless cardiac pacing device for heart failure, today announced that management will be presenting at the J.P. Morgan 2026 Healthcare Conference on Thursday, more...
Shenandoah Veterinary Associates Hospital Opens as a Local Pet Emergency Room Serving Roanoke and Southwestern Virginia
ROANOKE, Va.--(BUSINESS WIRE)--Pet owners in Roanoke and surrounding communities now have access to a uniquely modern, independently owned veterinary emergency hospital right in their own backyard. Shenandoah Veterinary Associates has officially opened its doors, providing more...
Record-breaking CIIE 2025 Achievements Signal Global Momentum
SHANGHAI--(BUSINESS WIRE)--The eighth China International Import Expo (CIIE) has concluded with record results, underscoring its growing global influence and China’s commitment to openness. Over six days, the expo welcomed 922,000 visits—an all-time high and an more...
HCA Healthcare UK Goes On “The Cloud” with MEDITECH Expanse EHR, Powering Patient-Centred Care
The new cloud-based EHR standardises care across the provider’s 11 hospitals and a growing outpatient network CANTON, Mass.--(BUSINESS WIRE)--Leading private healthcare provider, HCA Healthcare UK (HCA UK), is now live with MEDITECH Expanse across its more...
Takeda’s Zasocitinib Landmark Phase 3 Plaque Psoriasis Data Show Promise to Deliver Clear Skin in a Once-Daily Pill, Catalyzing a New Era of Treatment
Pivotal Phase 3 studies of once-daily oral zasocitinib met all primary and ranked secondary endpoints in patients with moderate-to-severe plaque psoriasis More than half of study participants treated with zasocitinib achieved clear or almost clear more...
DATROWAY® Type II Variation Application Validated in the EU as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who are Not Candidates for Immunotherapy
Based on TROPION-Breast02 phase 3 trial results where Daiichi Sankyo and AstraZeneca’s DATROWAY is the first and only medicine to significantly improve overall survival versus chemotherapy in this patient population If approved, DATROWAY could become more...
EDX Medical’s New Advanced Bowel Cancer Testing Service to Launch in UK to Improve Early Detection
CAMBRIDGE, England--(BUSINESS WIRE)--#EDXMedical--A new, highly accurate testing service that improves the early-stage detection of bowel cancer with strong clinical validity will be available in the UK within the next few weeks. The service increases the more...
PureTech Appoints Robert Lyne as Chief Executive Officer
BOSTON--(BUSINESS WIRE)--PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company"), a hub-and-spoke biotherapeutics company dedicated to giving life to science and transforming innovation into value, today announces that the Board of Directors has more...
Celltrion receives positive CHMP Opinion for SteQeyma™ (ustekinumab biosimilar) autoinjector
SteQeyma™ 45mg and 90mg solution for injection via autoinjector (pre-filled pen) receives positive CHMP opinion, which will facilitate subcutaneous administration in patients with plaque psoriasis, psoriatic arthritis (PsA) and Crohn’s disease (CD)1 The new autoinjector more...
Cosan Secures Strategic Growth Investment to Scale AI-Enabled, Team-Based Virtual Care for Chronic Conditions
CHICAGO--(BUSINESS WIRE)--Cosan, a connected chronic care management company helping providers extend care beyond the clinic, today announced a $15 million strategic growth equity investment led by Ziegler Link-age Funds and The Specialty Alliance, the nation’s more...
Aptar’s Bidose Nasal System Delivers CARDAMYST™ (etripamil), the First and Only Self-Administered FDA-Approved Nasal Spray for Paroxysmal Supraventricular Tachycardia (PSVT)
Novel treatment for PSVT developed with Milestone Pharmaceuticals CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar Group, Inc. (NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today announced that its Bidose (BDS) more...
MTF Biologics’ AmnioBand® Membrane and AlloPatch® Pliable Confirmed as Covered Under Updated CMS Local Coverage Determinations
EDISON, N.J.--(BUSINESS WIRE)--MTF Biologics, a global nonprofit organization that saves and heals lives by honoring donated gifts and advancing the science of tissue transplantation, today announced that two of its aseptically processed allografts without terminal more...
Antibacterial Products Market Worth $29.8 Billion by 2030: Rising Demand for Waterless Hygiene Options Spurs Growth in Sprays, Wipes, and Foams – ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Antibacterial Products Market - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. The global market for Antibacterial Products was valued at US$26.1 Billion in 2024 and is projected to reach US$29.8 more...